PF-4136309 (Synonyms: INCB8761, PF-04136309) |
Catalog No.GC25728 |
PF-4136309 (INCB8761, PF-04136309) is a potent, selective, and orally bioavailable CCR2 antagonist with an IC50 of 5.2 nM for human CCR2.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 857679-55-1
Sample solution is provided at 25 µL, 10mM.
PF-4136309 (INCB8761, PF-04136309) is a potent, selective, and orally bioavailable CCR2 antagonist with an IC50 of 5.2 nM for human CCR2.
PF-4136309 is potent in inhibiting CCR2 mediated signaling events such as intracellular calcium mobilization and ERK (extracellular signal-regulated kinase) phosphorylation. [1]
PF-4136309 exhibits >100-fold selectivity over other homologous chemokine receptors, a free fraction of 24% in human serum and 15% in mouse serum, and an oral bioavailability of 47% in mice, suitable as a tool compound for target validation in rodent models.[2]
[1] Xianming Deng, et, al. Eur J Med Chem. 2013;70:758-67. [2] Xue CB, et al. ACS Med Chem Lett. 2011 Oct 5;2(12):913-8.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *